ASCORBIC ACID

Molecular Excipient

Mwt. LogP HBD HBA PSA RB CSP3
175.0 -3.4 2 6 107.0 2 0.67
CAS
50817
UNII
PQ6CK8PD0R
SYNONYMS
ZINC ID(s)
Availability
Present in 1 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Dosages

Route Formulation Per Unit Dose
An,infiltration Injection
Caudal Block Injection
Epidural Injection
Im - Iv Injection 0.2%
Inhalation Aerosol, Metered 95.95%
Inhalation Aerosol, Spray 0.11%
Inhalation Solution 1.02%
Intramuscular Injection 1%
Intravenous Injection 12.5%W/V
Intravenous Powder, For Injection Solution 0.2%
Intravenous Powder, For Injection Solution, Lyophilized 0.09%
Intravenous Solution, Injection 0.44%
Iv(infusion) Injection 50.4%
Iv(infusion) Powder, For Injection Solution
Iv(infusion) Powder, For Injection Solution, Lyophilized 48%
Nerve Block Injection
Nerve Block Solution, Injection 0.2%
Oral Capsule 7MG
Oral Capsule, Extended Release 0.4MG
Oral Concentrate 0.6%
Oral Powder, For Oral Solution 5MG
Oral Solution 0.6%
Oral Suspension 1%
Oral Suspension, Sustained Action
Oral Syrup 0.25%
Oral Tablet 28.44MG
Oral Tablet, Film Coated 20MG
Rectal Suppository 3MG
Subcutaneous Injection 1%
Topical Gel 0.3%
Topical Solution 0.04%

More Information

Usage Over Time

Comments